Oritavancin Diphosphate + Drugs Metabolized By Cyp2d6 Interaction
Moderateinteraction on record
Description
Oritavancin is a weak CYP2C9 inhibitor; co-administration may increase or decrease concentrations of these drugs. Close monitoring for toxicity or lack of efficacy is recommended.
Mechanism
Weak CYP2C9 inhibition
Source: NLP:oritavancin diphosphate